Total Valuation
BioCube has a market cap or net worth of $97.00. The enterprise value is $10.62K.
Market Cap$97.00
Enterprise Value$10.62K
Share Statistics
BioCube has 96,742,760 shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding96,742,760
Owned by Insiders―
Owned by Institutions―
Financial Efficiency
BioCube’s return on equity (ROE) is 41.42 and return on invested capital (ROIC) is 0.00%.
Return on Equity (ROE)41.42
Return on Assets (ROA)0.00
Return on Invested Capital (ROIC)0.00%
Return on Capital Employed (ROCE)41.42
Revenue Per Employee0.00
Profits Per Employee-2.19K
Employee Count18
Asset Turnover0.00
Inventory Turnover0.00
Valuation Ratios
The current PE Ratio of BioCube is ―. BioCube’s PEG ratio is 0.00.
PE Ratio―
PS Ratio0.00
PB Ratio-682.39
Price to Fair Value-682.39
Price to FCF-26.62
Price to Operating Cash Flow-0.35
PEG Ratio0.00
Income Statement
In the last 12 months, BioCube had revenue of 0.00 and earned -39.35K in profits. Earnings per share was 0.00.
Revenue0.00
Gross Profit0.00
Operating Income-39.35K
Pretax Income-39.35K
Net Income-39.35K
EBITDA189.13K
Earnings Per Share (EPS)0.00
Cash Flow
In the last 12 months, operating cash flow was 2.97K and capital expenditures 0.00, giving a free cash flow of 2.97K billion.
Operating Cash Flow2.97K
Free Cash Flow2.97K
Free Cash Flow per Share<0.01
Dividends & Yields
BioCube pays an annual dividend of ―, resulting in a dividend yield of ―
Dividend Per Share―
Dividend Yield―
Payout RatioN/A
Free Cash Flow Yield―
Earnings Yield―
Stock Price Statistics
Beta0.10
52-Week Price Change0.00%
50-Day Moving Average―
200-Day Moving Average―
Relative Strength Index (RSI)100.00
Average Volume (3m)550.00
Important Dates
BioCube upcoming earnings date is ―, ―.
Last Earnings Date―
Next Earnings Date―
Ex-Dividend Date―
Financial Position
BioCube as a current ratio of 0.00, with Debt / Equity ratio of -100.00%
Current Ratio0.00
Quick Ratio0.00
Debt to Market Cap<0.01
Net Debt to EBITDA<0.01
Interest Coverage Ratio0.00
Taxes
In the past 12 months, BioCube has paid 0.00 in taxes.
Income Tax0.00
Effective Tax Rate0.00
Enterprise Valuation
BioCube EV to EBITDA ratio is 3.43, with an EV/FCF ratio of -26.66.
EV to Sales0.00
EV to EBITDA3.43
EV to Free Cash Flow-26.66
EV to Operating Cash Flow-26.66
Balance Sheet
BioCube has $9.12K in cash and marketable securities with $6.15K in debt, giving a net cash position of $2.97K billion.
Cash & Marketable Securities$9.12K
Total Debt$6.15K
Net Cash$2.97K
Net Cash Per Share<$0.01
Tangible Book Value Per Share>-$0.01
Margins
Gross margin is 0.00%, with operating margin of 0.00%, and net profit margin of 0.00%.
Gross Margin0.00%
Operating Margin0.00%
Pretax Margin0.00%
Net Profit Margin0.00%
EBITDA Margin0.00%
EBIT Margin0.00%
Analyst Forecast
The average price target for BioCube is ―, which is 11.43% higher than the current price. The consensus rating is ―
Price Target―
Price Target Upside―
Analyst Consensus―
Analyst Count0
Revenue Growth Forecast―
EPS Growth Forecast―